Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Voceryq
Published 2 weeks, 2 days ago
Description
FDA grants accelerated approval to INOVIO’s Voceryq to reduce surgical burden in recurrent respiratory papillomatosis, Brox.AI’s Hamish Brocklebank on the three levels of digital clone use cases in pharma, and CytoDyn’s Dr. Jay Lalezari on his path from HIV clinician to CEO.